Viral Inhibition in Children for Treatment of RSV

NCT02654171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Interventions

DRUG: AK0529
DRUG: Placebo

Sponsor

Shanghai Ark Biopharmaceutical Co., Ltd.

Collaborators

[object Object]